Patient Advocate Foundation logo
Jennifer Jaff Center Merges with Patient Advocate Foundation
May 02, 2016 09:14 ET | Patient Advocate Foundation
HAMPTON, Va., May 2, 2016 (GLOBE NEWSWIRE) -- The Jennifer Jaff Center, a respected national nonprofit for those suffering from chronic illness, has partnered with Patient Advocate Foundation to...
TradeStation Ranked
TradeStation Ranked One of America’s “Top Five” Online Brokers for Fourth Year in a Row and #1 for Equity Trading Tools for Third Year in a Row in Annual Investor’s Business Daily Survey of Active Investors
January 26, 2016 07:40 ET | TradeStation Group, Inc.
PLANTATION, Fla., Jan. 26, 2016 (GLOBE NEWSWIRE) -- TradeStation, a Monex Group company (Monex Group, Inc. is listed on the first section of the Tokyo Stock Exchange, code: 8698) and an...
Saint Arnold Brewing Co. logo
Feast of Saint Arnold to Raise $60,000 for Texas Children's Hospital
July 17, 2015 10:18 ET | Saint Arnold Brewing Co.
HOUSTON, July 17, 2015 (GLOBE NEWSWIRE) -- Saint Arnold Brewing Co. (www.saintarnold.com), the oldest craft brewery in Texas, expects its annual Feast of Saint Arnold event this weekend will raise...
TradeStation Ranked
TradeStation Ranked One of America's "Top Five" Online Brokers for Third Year in a Row and #1 for Equity Trading Tools for Second Year in a Row in Annual Investor's Business Daily Survey of Active Investors
January 26, 2015 07:40 ET | TradeStation Group, Inc.
PLANTATION, Fla., Jan. 26, 2015 (GLOBE NEWSWIRE) -- TradeStation, a Monex Group company (Monex Group, Inc. is listed on the first section of the Tokyo Stock Exchange code: 8698) and an award-winning...
Prof. John Zajicek
Photo Release -- Top Global Experts Join AXIM Biotechnologies Advisory Board
November 06, 2014 09:00 ET | AXIM BIOTECHNOLOGIES, INC
NEW YORK, Nov. 6, 2014 (GLOBE NEWSWIRE) -- AXIM Biotechnologies (OTC:AXIM) is setting the "green standard" in the industrial hemp industry, tapping two world-renown experts to advise on the Company's...
Qu Biologics Begins Research with McMaster University to Study New Crohn's Disease Research Model
December 03, 2013 10:00 ET | Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 3, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to stimulate the...
Qu Biologics Enrolls First Patient in Phase 1/2 Clinical Trial of QBECO SSI for the Treatment of Crohn's Disease
June 11, 2013 16:22 ET | Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 11, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...
Qu Biologics Welcomes Dr. Richard Fedorak and Dr. William Sandborn to Newly Formed IBD Advisory Team for Crohn's Disease Clinical Trial
May 30, 2013 13:43 ET | Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 30, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
Early Diagnosis and Public Awareness of Crohn's and Ulcerative Colitis Critical to Patient Care
November 23, 2011 09:00 ET | Crohn's & Colitis Foundation of Canada (CCFC)
TORONTO, ONTARIO--(Marketwire - Nov. 23, 2011) - Imagine experiencing agonizing and debilitating pain that lasts for hours, months and even a year without a Doctor or Medical Practitioner...
Research Indicates Synthetic Compound NV-52 May Be Useful in Treatment of Inflammatory Bowel Disease
November 13, 2007 08:04 ET | Novogen, Limited
NEW CANAAN, CT and SYDNEY, AUSTRALIA--(Marketwire - November 13, 2007) - An article published in a recent edition of the peer review journal Expert Opinion, Vol. 16, No. 8, reveals the compound...